IMC Chicago’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-17,293
Closed -$12.9M 3758
2025
Q2
$13.5M Buy
+17,293
New +$13.4M 0.01% 881
2025
Q1
Sell
-48,715
Closed -$40.5M 3322
2024
Q4
$37.6M Buy
48,715
+34,391
+240% +$28.5M 0.02% 419
2024
Q3
$12.7M Buy
+14,324
New +$12.9M 0.01% 729
2019
Q1
Sell
-4,103
Closed -$499K 789
2018
Q4
$475K Buy
+4,103
New +$458K ﹤0.01% 634

Other funds holding LLY

IMC Chicago's LLY Position: Q3 2025 in Review

IMC Chicago sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 17,293 shares — an estimated $12.9M sold.

IMC Chicago first reported a position in LLY in Q4 2018 and held it in 4 quarters. The position peaked at $37.6M in Q4 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • IMC Chicago reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • IMC Chicago sold 17,293 Eli Lilly shares in Q3 2025, an estimated $12.9M.
  • IMC Chicago first reported a position in Eli Lilly in Q4 2018 and held it in 4 quarters.
  • IMC Chicago's Eli Lilly position peaked at $37.6M in Q4 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on IMC Chicago's 13F filing for Q3 2025, filed 4 Nov 2025.